Cost-effectiveness of human papillomavirus vaccination in Germany.

about

Cost-effectiveness of human papillomavirus vaccination in Germany.

Item

http://www.wikidata.org/entity/Q40063569

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Cost-effectiveness of human papillomavirus vaccination in Germany.

@en

type

Item

label

Cost-effectiveness of human papillomavirus vaccination in Germany.

@en

prefLabel

Cost-effectiveness of human papillomavirus vaccination in Germany.

@en

P1476

Cost-effectiveness of human papillomavirus vaccination in Germany.

@en

P2093

Alexander Krämer

http://www.w3.org/2001/XMLSchema#string

Andreas M Kaufmann

http://www.w3.org/2001/XMLSchema#string

Bernhard Ultsch

http://www.w3.org/2001/XMLSchema#string

Johannes Horn

http://www.w3.org/2001/XMLSchema#string

Mirjam E E Kretzschmar

http://www.w3.org/2001/XMLSchema#string

Ole Wichmann

http://www.w3.org/2001/XMLSchema#string

Rafael T Mikolajczyk

http://www.w3.org/2001/XMLSchema#string

Wolfgang Greiner

http://www.w3.org/2001/XMLSchema#string

Yvonne Deleré

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males

Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts

The causal relation between human papillomavirus and cervical cancer.

Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus

Long-term efficacy and safety of human papillomavirus vaccination

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

Utilization of administrative data to assess the association of an adolescent health check-up with human papillomavirus vaccine uptake in Germany.

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.

P2888

s12962-017-0080-9

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12962-017-0080-9

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Oliver Damm

P577

2017-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091481836

http://www.w3.org/2001/XMLSchema#string

P698

28878573

http://www.w3.org/2001/XMLSchema#string

P921

A' Ghearmailt

P932

5583986

http://www.w3.org/2001/XMLSchema#string